Cargando…
Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions
Background Psoas muscle area (PMA) and density (PMD) measured using computed tomography are potential surrogates for evaluating sarcopenia-related mortality risk among patients undergoing cardiovascular interventions. However, the optimal measurement method remains unclear. Methods A retrospective r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519254/ https://www.ncbi.nlm.nih.gov/pubmed/37738519 http://dx.doi.org/10.1080/07853890.2023.2259798 |
_version_ | 1785109665568260096 |
---|---|
author | Järvinen, Otto Tynkkynen, Juho T. Virtanen, Marko Maaranen, Pasi Lindström, Iisa Vakhitov, Damir Laurikka, Jari Oksala, Niku K. Hernesniemi, Jussi A. |
author_facet | Järvinen, Otto Tynkkynen, Juho T. Virtanen, Marko Maaranen, Pasi Lindström, Iisa Vakhitov, Damir Laurikka, Jari Oksala, Niku K. Hernesniemi, Jussi A. |
author_sort | Järvinen, Otto |
collection | PubMed |
description | Background Psoas muscle area (PMA) and density (PMD) measured using computed tomography are potential surrogates for evaluating sarcopenia-related mortality risk among patients undergoing cardiovascular interventions. However, the optimal measurement method remains unclear. Methods A retrospective registry study of three observational cohorts comprising 2248 patients undergoing cardiovascular interventions (n = 828 for abdominal aortic aneurysms, n = 983 transcatheter aortic valve implantations, and 437 patients undergoing open surgery for thoracic aortic and aortic valve pathology) was conducted. Age-independent associations between mortality and PMA, PMD, PMA indexed to height or body surface area, and the combination of PMA and PMD (lean PMA) were meta-analyzed (using individual participant data) across cohorts after sex stratification with median follow-up times ranging from three to five years for each cohort. RESULTS: In the meta-analysis, psoas muscle measurements were significantly associated with mortality among men (p < 0.05), with high heterogeneity in the associations across all cohorts. There was very little difference in the association between PMA and PMD and mortality (HR 0.83, 95% CI 0.69–0.99, p = 0.002; HR 0.85, 95% CI 0.77–0.94, p = 0.041 for one SD increase in PMA and PMD in the random effects model). Combining PMA and PMD into one composite variable by multiplying their values together showed the most robust association in terms of the magnitude of the effect size in men (HR, 0.77; 95% CI 0.73–0.87, p < 0.001). Indexing PMA to body size did not result in any significant differences in this association. Among women, psoas muscle measurements were not associated with long-term mortality in this meta-analysis. CONCLUSIONS: Different psoas muscle measurements were significantly and very similarly associated with mortality among men but not among women. No single measurement stands out, although combining PMA and PMD seems to be a slightly stronger estimate in terms of effect size and should be considered in further studies. |
format | Online Article Text |
id | pubmed-10519254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-105192542023-09-26 Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions Järvinen, Otto Tynkkynen, Juho T. Virtanen, Marko Maaranen, Pasi Lindström, Iisa Vakhitov, Damir Laurikka, Jari Oksala, Niku K. Hernesniemi, Jussi A. Ann Med Cardiology & Cardiovascular Disorders Background Psoas muscle area (PMA) and density (PMD) measured using computed tomography are potential surrogates for evaluating sarcopenia-related mortality risk among patients undergoing cardiovascular interventions. However, the optimal measurement method remains unclear. Methods A retrospective registry study of three observational cohorts comprising 2248 patients undergoing cardiovascular interventions (n = 828 for abdominal aortic aneurysms, n = 983 transcatheter aortic valve implantations, and 437 patients undergoing open surgery for thoracic aortic and aortic valve pathology) was conducted. Age-independent associations between mortality and PMA, PMD, PMA indexed to height or body surface area, and the combination of PMA and PMD (lean PMA) were meta-analyzed (using individual participant data) across cohorts after sex stratification with median follow-up times ranging from three to five years for each cohort. RESULTS: In the meta-analysis, psoas muscle measurements were significantly associated with mortality among men (p < 0.05), with high heterogeneity in the associations across all cohorts. There was very little difference in the association between PMA and PMD and mortality (HR 0.83, 95% CI 0.69–0.99, p = 0.002; HR 0.85, 95% CI 0.77–0.94, p = 0.041 for one SD increase in PMA and PMD in the random effects model). Combining PMA and PMD into one composite variable by multiplying their values together showed the most robust association in terms of the magnitude of the effect size in men (HR, 0.77; 95% CI 0.73–0.87, p < 0.001). Indexing PMA to body size did not result in any significant differences in this association. Among women, psoas muscle measurements were not associated with long-term mortality in this meta-analysis. CONCLUSIONS: Different psoas muscle measurements were significantly and very similarly associated with mortality among men but not among women. No single measurement stands out, although combining PMA and PMD seems to be a slightly stronger estimate in terms of effect size and should be considered in further studies. Taylor & Francis 2023-09-22 /pmc/articles/PMC10519254/ /pubmed/37738519 http://dx.doi.org/10.1080/07853890.2023.2259798 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Cardiology & Cardiovascular Disorders Järvinen, Otto Tynkkynen, Juho T. Virtanen, Marko Maaranen, Pasi Lindström, Iisa Vakhitov, Damir Laurikka, Jari Oksala, Niku K. Hernesniemi, Jussi A. Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions |
title | Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions |
title_full | Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions |
title_fullStr | Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions |
title_full_unstemmed | Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions |
title_short | Psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions |
title_sort | psoas muscle quantified muscle status and long-term mortality after cardiovascular interventions |
topic | Cardiology & Cardiovascular Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519254/ https://www.ncbi.nlm.nih.gov/pubmed/37738519 http://dx.doi.org/10.1080/07853890.2023.2259798 |
work_keys_str_mv | AT jarvinenotto psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT tynkkynenjuhot psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT virtanenmarko psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT maaranenpasi psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT lindstromiisa psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT vakhitovdamir psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT laurikkajari psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT oksalanikuk psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions AT hernesniemijussia psoasmusclequantifiedmusclestatusandlongtermmortalityaftercardiovascularinterventions |